Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Risingsong

Prevention and Treatment of Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268

Clinical Cancer Research

Cancer Research

Oncology

2008

English

Novel Semisynthetic Analogues of Betulinic Acid With Diverse Cytoprotective, Antiproliferative, and Proapoptotic Activities

Molecular Cancer Therapeutics

Cancer Research

Oncology

2007

English

Related publications

The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice

Cancer Prevention Research

English

The SERM, Arzoxifene, and the Rexinoid, LG100268, Cooperate to Prevent Estrogen Receptor-Positive and -Negative Breast Cancer as Well as Colon Cancer.

English

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer

Scientific Reports

Multidisciplinary

2020

English

Increased Estrogen Receptor Cx Expression During Mammary Carcinogenesis

Clinical Cancer Research

Cancer Research

Oncology

2005

English

The Synthetic Triterpenoid, CDDO-Me, Modulates the Proinflammatory Response toIn VivoLipopolysaccharide Challenge

Journal of Interferon and Cytokine Research

English

Prevention of Prostate Cancer With Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer

English

Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription

PLoS ONE

Multidisciplinary

2009

English

N-Methyl-N-Nitrosourea-Induced Mammary Carcinogenesis Is Promoted by Short-Term Treatment With Estrogen and Progesterone Mimicking Pregnancy in Aged Female Lewis Rats

English

Neonatal Experiences Differentially Influence Mammary Gland Morphology, Estrogen Receptor Protein Levels, and Carcinogenesis in BALB/c Mice

Cancer Prevention Research

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Risingsong

Prevention and Treatment of Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268

Novel Semisynthetic Analogues of Betulinic Acid With Diverse Cytoprotective, Antiproliferative, and Proapoptotic Activities

Related publications

The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice

The SERM, Arzoxifene, and the Rexinoid, LG100268, Cooperate to Prevent Estrogen Receptor-Positive and -Negative Breast Cancer as Well as Colon Cancer.

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer

Increased Estrogen Receptor Cx Expression During Mammary Carcinogenesis

The Synthetic Triterpenoid, CDDO-Me, Modulates the Proinflammatory Response toIn VivoLipopolysaccharide Challenge

Prevention of Prostate Cancer With Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer

Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription

N-Methyl-N-Nitrosourea-Induced Mammary Carcinogenesis Is Promoted by Short-Term Treatment With Estrogen and Progesterone Mimicking Pregnancy in Aged Female Lewis Rats

Neonatal Experiences Differentially Influence Mammary Gland Morphology, Estrogen Receptor Protein Levels, and Carcinogenesis in BALB/c Mice